VREOF - Vireo Health International Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
95.02M
Enterprise Value 3
84.99M
Trailing P/E
N/A
Forward P/E 1
N/A
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
4.04
Price/Book (mrq)
0.78
Enterprise Value/Revenue 3
3.61
Enterprise Value/EBITDA 6
9.39

Trading Information

Stock Price History

Beta (3Y Monthly) N/A
52-Week Change 3∞%
S&P500 52-Week Change 39.10%
52 Week High 35.0626
52 Week Low 31.0575
50-Day Moving Average 31.4369
200-Day Moving Average 32.4705

Share Statistics

Avg Vol (3 month) 338.28k
Avg Vol (10 day) 337.19k
Shares Outstanding 521.64M
Float 23.52M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 219/1
Last Split Date 3Mar 20, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin -27.58%
Operating Margin (ttm)33.58%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)23.52M
Revenue Per Share (ttm)0.30
Quarterly Revenue Growth (yoy)70.10%
Gross Profit (ttm)16.78M
EBITDA 9.06M
Net Income Avi to Common (ttm)-6.49M
Diluted EPS (ttm)-0.0830
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)30.34M
Total Cash Per Share (mrq)0.39
Total Debt (mrq)21.57M
Total Debt/Equity (mrq)19.22
Current Ratio (mrq)7.40
Book Value Per Share (mrq)1.44

Cash Flow Statement

Operating Cash Flow (ttm)-15.42M
Levered Free Cash Flow (ttm)N/A